These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 30831151)

  • 1. Grem2 mediates podocyte apoptosis in high glucose milieu.
    Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC
    Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
    Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
    J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perilipin2 inhibits diabetic nephropathy-induced podocyte apoptosis by activating the PPARγ signaling pathway.
    Dai ZW; Cai KD; Xu LC; Wang LL
    Mol Cell Probes; 2020 Oct; 53():101584. PubMed ID: 32387304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 6. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
    Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
    Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
    Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
    Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EDA2R mediates podocyte injury in high glucose milieu.
    Lan X; Kumar V; Jha A; Aslam R; Wang H; Chen K; Yu Y; He W; Chen F; Luo H; Malhotra A; Singhal PC
    Biochimie; 2020 Jul; 174():74-83. PubMed ID: 32304771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect on podocyte number in experimental diabetic nephropathy resulting from combined atrasentan and RAAS inhibition therapy.
    Hudkins KL; Wietecha TA; Steegh F; Alpers CE
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1295-F1305. PubMed ID: 32249614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte.
    Jin J; Shi Y; Gong J; Zhao L; Li Y; He Q; Huang H
    Stem Cell Res Ther; 2019 Mar; 10(1):95. PubMed ID: 30876481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway.
    Li G; Li Y; Liu S; Shi Y; Chi Y; Liu G; Shan T
    J Cell Biochem; 2013 Sep; 114(9):2101-13. PubMed ID: 23553804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
    Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y
    Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of serum response factor in podocyte epithelial-mesenchymal transition of diabetic nephropathy.
    Zhao L; Wang X; Sun L; Nie H; Liu X; Chen Z; Guan G
    Diab Vasc Dis Res; 2016 Jan; 13(1):81-92. PubMed ID: 26408645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sam68 mediates high glucose‑induced podocyte apoptosis through modulation of Bax/Bcl‑2.
    Chen Y; Zhang L; Liu S; Yao B; Zhang H; Liang S; Ma J; Liang X; Shi W
    Mol Med Rep; 2019 Oct; 20(4):3728-3734. PubMed ID: 31485651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 4 mediates high glucose-induced podocyte apoptosis via upregulation of calcineurin.
    Shi W; Huang Y; Zhao X; Xie Z; Dong W; Li R; Chen Y; Li Z; Wang W; Ye Z; Liu S; Zhang L; Liang X
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1061-1068. PubMed ID: 33019979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
    Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.